Login / Signup

Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial.

Tian-Lian YanJing-Hua WangXin-Jue HeYa-Bi ZhuLin-Jie LuYan-Jiao WangZi-Wei WangJian-Guo GaoCheng-Fu XuHan MaShuang-Mei LuanLan LiYi Chen
Published in: The American journal of gastroenterology (2023)
ChiCTR2300070100.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • double blind
  • cross sectional
  • stem cells
  • bone marrow
  • visible light
  • replacement therapy